NCT02260271
Florida Neonatal Neurologic Network
Enrolling by Invitation
Not specifiedAges 1–3ObservationalUniversity of FloridaInvestigator-initiated
~1,000 participants
Updated 2026-02-11 on ClinicalTrials.gov
What's tested:Database Entry/Biospecimen Collection
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Measurement of blood-based biomarkers of neonatal Hypoxic Ischemic Encephalopathy (HIE)
Measured over 2 years
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Michael D Weiss, MD · PRINCIPAL_INVESTIGATOR · University of Florida
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Gestational Age greater than or equal to 35 weeks gestation
Birth weight greater than or equal to 1.8 kg
Less than or equal to 6 hours since insult occurred
Severe hypoxic-ischemic encepholopathy (HIE)
Exclusion
Presence of lethal chromosomal abnormalities
Severe IUGR
Significant intracranial hemorrhage with a large intracranial hemorrhage (Grade III or intraparenchymal echodensity (Grade IV))
What this trial measures
- Measurement of blood-based biomarkers of neonatal Hypoxic Ischemic Encephalopathy (HIE)2 years
Measure HIE biomarker levels in blood samples obtained in infants born with HIE.